Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1

Fig. 2

Expression and activation of caspase1, 3, and 8 in 4T1 (A) and MDA-MB-231 (B) cells under different treatments. Protein levels of HMGB1 and CRT in 4T1 (C) and MDA-MB-231 (D) cells under different treatments. Immunofluorescence staining of CRT (E) and HMGB1 (F) in 4T1 cells after different treatments. HMGB1 (G) release and ATP (H) secretion from 4T1 cells after different treatments (measured by an ELISA kit)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us